Quarterly Results, Broker Conferences, Special IR Events FY2019 (April 2019-March 2020)

IR meeting with analysts and investors with Julie Kim, President of Takeda's Plasma-Derived Therapies Business Unit (Held on October 10, 2019)

Morgan Stanley Healthcare Conference (Held on September 10, 2019 ET)

Audio
*Link to conference website

FY2019 Q1 Results (released on July 31, 2019)

Partial Correction of Financial Statements submitted to TSE (Tokyo Stock Exchange)
Click to download


Consolidated Financial Statements submitted to TSE (Tokyo Stock Exchange)

(Without Independent Auditor’s report)
Click to download


Press Release
 

Data Book
Click to download


Earnings Release Presentation

CONSOLIDATED FINANCIAL RESULTS FOR FY2019 Q1
Costa Saroukos, Chief Financial Officer
Click to download


Supplementary materials for the financial statements

Underlying Core Reconciliation
Click to download

Financial FAQs regarding FY2019 Q1 earnings
Click to download


Audio Conference Call

IR Seminar “Plasma-Derived Therapies Business” (Held on July 12, 2019)

Quarterly Results, Broker Conferences, Special IR Events Archive